Edgestream Partners’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Other funds holding DGX
EIG
Edgestream Partners's DGX Position: Q1 2026 in Review
Edgestream Partners sold out of Quest Diagnostics (DGX) in Q1 2026, closing a stake of 2,050 shares — an estimated $356K sold.
Edgestream Partners first reported a position in DGX in Q1 2017 and held it in 14 quarters. The position peaked at $4.18M in Q4 2024. 1,069 funds tracked by Wall St. Rank hold DGX as of Q1 2026.
- Edgestream Partners reported no remaining Quest Diagnostics position as of Q1 2026 after selling out during the quarter.
- Edgestream Partners sold 2,050 Quest Diagnostics shares in Q1 2026, an estimated $356K.
- Edgestream Partners first reported a position in Quest Diagnostics in Q1 2017 and held it in 14 quarters.
- Edgestream Partners's Quest Diagnostics position peaked at $4.18M in Q4 2024.
- 1,069 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.
Based on Edgestream Partners's 13F filing for Q1 2026, filed 18 May 2026.